Targeted manipulation of the genome has greatly improved our understanding of the mechanisms responsible for development; however, many such genetic manipulations result in severe abnormalities and high mortality rates. Understanding cell autonomy of defects often also necessitates a more targeted approach than eliminating or overexpressing a gene. Cre-lox technology, in which Cre recombinase excises or inverts the sequence flanked by LoxP sites, depending on the orientation of the sites, allows for targeted activation or inactivation of DNA sequences [1] . Using this technology has enabled researchers to target specific populations of cells or specific time points. Characterizing and disseminating various Cre transgenic lines allows researchers to refine experiments and ask better informed questions.
Genotyping: Tissue biopsies (toe tips or tail tips) were taken from the mice and then prepared for PCR by first boiling the samples in 50 μl of 25 μM sodium hydroxide and 0.2 μm EDTA for 15 min. Fifty microliters of Tris Cl (pH 5.0) was then added to the samples, neutralizing them. Each PCR reaction consisted of 7.5 μl of OneTaq Hot Start Master Mix (2X, New England Biolabs, Ipswich, MA) [13] , 0.1 μl primers, 1 μl of DNA sample, and 6.4 μl of nuclease-free water, bringing the final volume to 15 μl. PCR conditions: (36 cycles; 94 °C 30 s, 57 °C 30 s, 72 °C 2 min). The following primers were used when genotyping: Pou4f2 forward (#1, Figure 1A ): 5′-GCT GAG GTC TGA AGC CAG AG-3′, Pou4f2 reverse (#2, Figure 1A ): 5′-CAG TCA GCT CCT CGC TTT CT-3′; Cre forward (#3, Figure 1B ): 5′-GCA TTA CCG GTC GAT GCA ACG AGT G-3′, Cre reverse (#4, Figure 1B ): 5′-GAG TGA ACG AAC CTG GTC GAA ATC A-3′; and neomycin forward (#6, Figure 1B ): 5′-AGG ATC TCC TGT CAT CTC ACC TTG CTC CTG-3′, neomycin reverse (#5, Figure 1B ): 5′-AAG AAC TCG TCA AGA AGG CGA TAG AAG GCG-3′.
Tissue preparation: Mice were anesthetized with an intraperitoneal injection of tribromoethanol (500 mg per kg body weight). Anesthetized mice were perfused with PBS (1X; 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 ; 1.8 mM KPO 4 ), pH 7.4. The eyes were then carefully removed using forceps and dissected in PBS to remove the cornea, iris, and lens. Eyes were fixed in 4% paraformaldehyde (PFA) solution for Cre construct and locations of the designed primers. The construct consisting of an internal ribosome entry site (IRES) Cre, fused to exon 1, and an inverted neomycin cassette. C: PCR product showing the DNA sequence unique to Pou4f2
Cre , compared to the wild-type. These bands were sequenced to confirm the authenticity of the bands. D: PCR was used to determine the zygosity of Cre. Pou4f2 +/+ mice were Pou4f2 positive and Cre negative. Pou4f2
Cre/+ mice were Pou4f2 and Cre positive. Pou4f2 Cre/Cre mice were Pou4f2 negative and Cre positive. E: Retina whole mounts immunostained for POU4F1 (BRN3A) and POU4F2 (BRN3B). F: Retinal cryosections immunostained for POU4F1 and POU4F2. The Pou4f2
Cre/Cre retinas display a large reduction in POU4F1-positive cells and no POU4F2 immunoreactivity. G: 4,6-diamidino-2-phenylindole (DAPI) staining for the panel. F: No significant difference was found between the POU4F1-and POU4F2-positive cells across the Pou4f2
Cre/+ and Pou4f2 +/+ retinas (data not shown). Scale bar = 100 μm.
30 min at room temperature, and the retina was dissected from the eyecup. Fixed retinas were sunk in 30% sucrose overnight before freezing. Sucrose sunk tissues were placed in Tissue-Tek optimal cutting temperature (OCT) media (Sakura Finetek, Torrance, CA) and frozen by placing the block above liquid nitrogen to rapidly freeze the sample. Retinas were then sectioned at 10 μm and placed onto charged slides. Whole fixed retinas were washed thoroughly in PBS and then stained. All other tissues were fixed in 4% PFA overnight at 4 °C and washed thoroughly with PBS. Tissues for cryosectioning were handled in the same manner as the retinas. Brains that were used for the vibratome sections were placed in a 6% agarose block, sectioned at 150 μm thickness, and stained with 4,6-diamidino-2-phenylindole (DAPI) reagent at a dilution of 1:50,000 of 1 mg/ml stock.
Immunohistochemistry:
Sections-Tissues were blocked in a blocking solution (5% normal donkey serum, 0.1% Triton X-100, and PBS) for 30 min at room temperature. Blocking solution was used to dilute the primary antibodies. Sections were incubated in primary antibodies overnight at 4 °C. Sections were then washed in PBS at room temperature three times before secondary staining. Secondary antibodies were also diluted in blocking solution and incubated overnight at 4 °C. Sections were again washed three times in PBS at room temperature. DAPI was added to the second wash at a concentration of 1:50,000 from 1 mg /ml stock. Coverslips were applied using 80% glycerol as a mounting medium.
Whole retinas-Whole retinas were stained in a similar manner except the blocking solution used was composed of 5% normal donkey serum, 0.4% Triton X-100, and PBS, blocking was performed at 4 °C overnight. Both primary and secondary incubations lasted 2-4 days at 4 °C, and the final wash was performed in 0.4% Triton blocking solution overnight at 4 °C.
Antibodies:
The following antibodies were used in this study: mouse anti-POU4F1/BRN3A (Millipore, Darmstadt, Germany; MAB1585; 1:100); goat anti-POU4F2/BRN3B (Santa Cruz Biotechnology, Santa Cruz, CA; sc-6026; 1:100); rabbit anti-melanopsin (generous gift from Ignacio Provencio; 1:10,000); rabbit anti-tyrosine hydroxylase (Millipore; AB152; 1:500); mouse anti-AP2α (Developmental Studies Hybridoma Bank, Trevor J. Williams; 3B5; 1:50); rabbit anti-calbindin (Swant, Marly, Switzerland; CB-38a; 1:1,000); goat anticholine acetyltansferase (Millipore; AB144P; 1:250); rabbit anti-bNOS (Sigma, St. Louis, MO; N7280; 1:5,000); mouse anti-PKCα (Santa Cruz Biotechnology, sc-17769; 1:500); rabbit anti-cone arrestin (Millipore; AB15282; 1:10,000); mouse anti-glutamine synthetase (Millipore; MAB302; 1:1,000); mouse anti-calsenilin (Millipore; 05-756; 1:1,000); mouse anti-PAX6 (developed by Kawakami, Developmental Studies Hybridoma; 1:500); and rabbit anti-Cre (Millipore; 69,050-3; 1:500). All secondary antibodies were used at 1:1,000 (Jackson ImmunoResearch, West Grove, PA).
Fluorescent microscopy: Sections and whole retinas were imaged using an Olympus (Center Valley, PA) or Nikon (Melville, NY) spinning disk confocal microscope or an Olympus FluoView confocal microscope. Adobe Photoshop (CS6; San Jose, CA) was used to crop and rotate the images. If brightness or contrast was altered, it was done uniformly across the entire image.
RESULTS

Pou4f2
Cre can be used to deplete RGCs: The Pou4f2 Cre transgenic line used in this study was previously generated but never characterized [10] . As the method used to generate the mice was not known, numerous primers were designed specific to the native Pou4f2 sequence and Cre recombinase to determine the site of Cre insertion within the Pou4f2 locus ( Figure 1A ,B and not shown). Additionally, primers designed specifically for neomycin were created to determine whether this cassette still remained within the transgene ( Figure 1B ). Through the use of PCR and sequencing of the PCR products, we successfully mapped the location of Pou4f2
Cre ( Figure  1C and not shown). The inserted transgene consists of an internal ribosome entry site (IRES) Cre fused to exon 1 of the native Pou4f2 sequence and an inverted neomycin cassette ( Figure 1B ). Homozygous carriers of the transgene can be differentiated from heterozygotes by the lack of the Pou4f2 gene, assayed with PCR ( Figure 1D ). Elimination of POU4F2 (BRN3B) immunoreactivity in the retina and a reduction in RGCs, assayed with an antibody to the homologous protein POU4F1 (BRN3A), was observed in mice homozygous for Cre recombinase, consistent with previous investigations of Pou4f2 function [2, 3] (Figure 1E -G).
Location of Pou4f2
Cre recombination is dependent upon breeding scheme: To test the efficiency and location of Pou4f2
Cre recombination activity, Pou4f2 Cre mice were crossed to a mouse strain carrying a sensitive and ubiquitously expressed Cre reporter, Ai9 [11] . The Ai9 reporter ( Figure  2A ) is driven by the CAG promoter, which is followed by a LoxP-flanked transcription termination cassette and red fluorescent protein (RFP). Upon Cre-mediated recombination, the transcription termination cassette is removed, allowing for the transcription of RFP. This results in the production of RFP in tissues that have expressed Cre recombinase. Cre and the reporter. Bi: Ubiquitous production of RFP in offspring when Pou4f2 Cre and Ai9 are carried by the sire. Bii-iv: Pou4f2
Cre specific recombination was observed in offspring when the sire carries Pou4f2 Cre and the dam carries Ai9 (ii), Pou4f2
Cre and Ai9 are carried by the dam (iii), or Ai9 is carried by the sire and the dam carries Pou4f2
Cre (iv). C-E: Images of cryosections and tissue biopsies (ear) that are counterstained with 4,6-diamidino-2-phenylindole (DAPI). C: No RFP was detected in mice that carried Ai9 only. D: Offspring with germline recombination. RFP was detected throughout all tissues. E: Offspring with Pou4f2
Cre -specific recombination. RFP was detected in the retina, brain, intestine, heart, and gonads. Scale bars = 100 μm (retina-kidney, scale bar in the retina image; ear punch, scale bar in the image).
Cre activity was determined by visualization of RFP in cryosections and tissue biopsies of mouse tissues ( Figure  2C -E). The pattern of recombination was dependent upon which parent carried the Cre and the target of Cre. When the sire carried Pou4f2
Cre and Ai9, germline recombination occurred ( Figure 2B,D) . Germline recombination of the reporter was observed in offspring regardless of whether they inherited Pou4f2
Cre , verified with PCR (not shown), suggesting that recombination was targeted in the germline. RFP was observed within the testis of sexually mature mice that carried Pou4f2
Cre and the Ai9 reporter ( Figure  2E ), consistent with these results and previous reports that Pou4f2 is expressed within germ cells [14, 15] . When the sire carried Pou4f2
Cre and the dam carried the reporter, recombination was limited to subsets of cells within the retina, brain, intestines, heart, and gonads (Figure 2Bii ,E). When the dam carried Pou4f2
Cre , recombination was limited to subsets of cells within the retina, brain, intestines, heart, and gonads, regardless of which parent carried the reporter allele ( Figure  2Biii -iv,E). No visualization of the Ai9 reporter was detected in the mice that lacked Pou4f2
Cre ( Figure 2C ).
Pou4f2
Cre -mediated recombination within the retina: To test the specificity of Pou4f2
Cre expression within the retina, Pou4f2
Cre/+ Ai9 retinal sections from crosses generating specific recombination (Figure 2Bii -iv,E) were immunostained with a panel of cell-type specific markers ( Figure  3 , Figure 4 , and Table 1 ). Reporter activity was limited to neurons but was also detected in neuron populations not known to express Pou4f2. Recombination was observed in RGCs ( Figure 3A,B) , amacrine cells (ACs; Figure 3C -E and Figure 4A -B), bipolar cells (BCs; Figure 4C ), horizontal cells (HCs; Figure 3D) , and a very small number of photoreceptors ( Figure 4D ). No Cre activity was detected within the microglia, astrocytes, or blood vessels (not shown). Müller glia were also not normally targeted by Cre ( Figure 4E ,E''). However, one of the 34 mice observed in this study contained columns of cells that produced RFP, suggesting that a small number of retinal progenitor cells had expressed Cre (not shown). For the majority of markers used in this study, only a portion of the cells produced RFP, with the exception of POU4F2, where all counted cells produced RFP (Table 1) .
Cre/+ mice were also crossed with mice carrying the Brainbow reporter ( Figure 4F ). The Brainbow reporter is a transgene driven by the Thy1 promoter that encodes a series of fluorescent proteins, each flanked by LoxP sites [16] . This genetic construct allows for differential expression and visualization of fluorescent proteins. Cre expression within the retina was again limited to neurons within the retina but only those that express Thy1: RGCs, ACs, and HCs ( Figure 4F ).
Cre/+ Ai9 retinal sections were taken from crosses that generated a specific recombination to map out the developmental time course at which Pou4f2
Cre targeted recombination in different cell populations (Figure 2Bii-iv,E) . The proportion of cells producing RFP and positive for specific markers were quantified at P0, P10, P20, and P40 ( Figure 5 ). The proportion of cells positive for RFP and PAX6, ChAT, and calsenilin increased incrementally from P0 to P40, while POU4F2-positive cells were all targeted starting from P0, the earliest time point sampled (Figure 5A-I ). Immunohistochemistry was then used to detect the location of the Cre protein ( Figure 5J-M) . The Cre protein was observed within the neurites and nuclei of cells in which recombination occurred ( Figure 5J ), while staining was absent in retinal sections taken from mice that lacked Cre ( Figure 5K Figure 5N ).
Cre activity within the brain: Pou4f2 Cre/+ Ai9 brains from crosses that generated a specific recombination were imaged to test the specificity of Pou4f2
Cre expression within the brain (Figure 2Bii-iv,E) . RFP was observed in many regions of the brain ( Figure 6 ). The expression of RFP was observed in retinal ganglion cell axons projecting throughout the brain but was also found within neural cell bodies and their neurites in other regions of the brain, including the visual centers, consistent with previous studies [9, 18] 
. The percentage of cells targeted by Pou4f2
Cre within three visual centers was determined: the suprachiasmatic nucleus (SCN), the lateral geniculate nucleus (LGN), and the superior colliculus (SC; Figure 7 ). This was accomplished by staining vibratome sections of the brain with DAPI and counting the total number of cells positive for RFP. Our results indicate that 18% of cells within the SCN had expressed Cre, 11% in the LGN, and 17% in the SC (Figure 7D-G) . Cre -mediated recombination within the retina. Cre-mediated recombination within the retina was assayed in Pou4f2
Cre/+ Ai9 mice by immunostaining retinal cryosections with a panel of markers. Channels are split out for better visualization. Markers are described in further detail in Table 1 . Abbreviations: mela = melanopsin, Calb = calbindin. Scale bars = 50 μm. Insets = 16 μm boxes. 
DISCUSSION
This study characterized a Pou4f2
Cre transgenic mouse line, in which Cre recombinase is driven by the Pou4f2 promoter. Our results show that this transgenic mouse can be used (1) to deplete RGC populations when homozygous for the Pou4f2
Cre , (2) that the pattern of Cre recombination is dependent upon which parent carries Pou4f2
Cre and the target of recombination, making it useful to target germline recombination, (3) that Cre specific activity within the retina is limited to the neurons (RGCs, ACs, BCs, HCs, and a small number of photoreceptors), and (4) that the timing of Pou4f2
Cre recombination is subclass specific. These properties make this line a useful multipurpose genetic reagent for vision researchers.
The Pou4f2
Cre knock-in transgenic mouse can be used to generate RGC-specific depletion, consistent with previous literature demonstrating that deletion of Pou4f2 results in the depletion of about 70% of the RGCs [2, 3] . Previous studies have also shown that the remaining RGCs within Pou4f2 knockout mice maintain normal RGC diversity and a grossly normal morphology [19] . Using the Pou4f2
Cre transgenic mouse line to drastically reduce RGC populations allows questions to be asked about how retinas develop without normal populations of RGCs and the effects major depletion of RGCs has on the developing retina.
Cre line can also be used to target recombination in the germline, depending on which parent carries the Pou4f2
Cre and the target for recombination. Germline recombination occurs when the sire carried the Pou4f2
Cre gene and the target for recombination yet was always specific when the dam carried Pou4f2
Cre . This was an interesting observation consistent with the expression of Pou4f2 in the male and female germline and suggests that the Pou4f2
Cre transgenic mouse line could be used to understand the genetic underpinnings of varying germline development between sexes [14, 15] . In crosses, we have established using floxed alleles of the target genes that the recombination rate is complete, resulting in 100% transmission of recombined alleles, which increases the efficiency of producing mice that carry mutations that would otherwise prevent or reduce breeding efficiency.
The activity of Pou4f2
Cre recombination was observed in multiple populations of cells in the retina. Here we mapped patterns of recombination using two reporter lines, Ai9 and Brainbow. The Pou4f2
Cre line targets RGCs during early stages of retinal development and would be useful for studying processes such as RGC axon guidance. At later time points, recombination is observed within neurons in the retinal ganglion cell layer, the inner nuclear layer, and a small number of photoreceptors. The Brainbow reporter was observed only in RGCs, ACs, and HCs, consistent with activity of the Thy1 promoter. The expression of Cre from the Pou4f2 locus differs from immunohistological studies in which RGCs are the primary cell type of the retina expressing Pou4f2
Cre and related proteins [9] . The IRES sequence added to the construct is highly GC-rich, and such sequences are likely to alter local DNA methylation patterns. We speculate that this is why the expression pattern of Cre also differs from a recently reported Pou4f2 Dre/Cre line [18] . In this line, Dre-mediated recombination replaces the Pou4f2 gene with Cre. The Cre driven from the Pou4f2 locus in this transgenic mouse is observed in the entire animal, which is different compared to the expression pattern of Pou4f2 as detected in situ [18] . These results suggest that expression driven from the Pou4f2 locus is highly sensitive to small changes, such as those made in engineering the recombinant lines and could account for the expression of Cre in non-RGC populations in the retina reported in this study. Alternatively, this could reflect low expression of Pou4f2 in these cell types (i.e., ACs).
We also report that the timing of Pou4f2
Cre -mediated recombination within the retina is also highly dependent upon the cell type in which the target of recombination is located. By taking advantage of the timing of this recombination pattern, investigators will have a reproducible method to target amacrine and bipolar cells after the completion of developmental processes such as developmental cell death and dendrite outgrowth to complement the use of Cre:ER lines. Sparse recombination was also observed in the neurons of the enteric nervous system, photoreceptors, and some other regions of the brain, allowing for genetic manipulations to be targeted in a small number of cells.
In conclusion, this study characterizes a transgenic Pou4f2 knock-in Cre recombinase transgenic mouse line. This line can be used to deplete RGC number, to target germline recombination, and to target recombination in retinal neurons while sparing Müller glia and most photoreceptors.
